These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10590404)

  • 1. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy.
    Gorson KC; Ropper AH; Adelman LS; Weinberg DH
    Muscle Nerve; 2000 Jan; 23(1):37-43. PubMed ID: 10590404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
    Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
    J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
    Jann S; Bramerio MA; Facchetti D; Sterzi R
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.
    Uncini A; De Angelis MV; Di Muzio A; Callegarini C; Ciucci G; Antonini G; Lugaresi A; Gambi D
    Clin Neurophysiol; 1999 Apr; 110(4):705-11. PubMed ID: 10378742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
    Gorson KC; Allam G; Ropper AH
    Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
    Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
    J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
    Thaisetthawatkul P; Logigian EL; Herrmann DN
    Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.
    Sharma KR; Cross J; Ayyar DR; Martinez-Arizala A; Bradley WG
    Arch Neurol; 2002 May; 59(5):751-7. PubMed ID: 12020256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
    Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
    Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
    Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
    PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
    Ohashi N; Kodaira M; Morita H; Sekijima Y
    Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders.
    Bromberg MB; Albers JW
    Muscle Nerve; 1993 Mar; 16(3):262-6. PubMed ID: 8383290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.
    Notermans NC; Franssen H; Eurelings M; Van der Graaf Y; Wokke JH
    Muscle Nerve; 2000 Jan; 23(1):73-9. PubMed ID: 10590408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.